Avior Bio is a clinical-stage, pharmaceutical company developing drugs for distressed neurological conditions.
Business Model:
Revenue: $0
Employees: 11-50
Address: Suite 200
City: Durham
State: NC
Zip: 27701
Country: US
Avior Bio is a clinical-stage, pharmaceutical company developing drugs for distressed neurological conditions. Using its disruptive drug delivery technology – Speedit™ Transmucosal Film Technology – we are positioned to develop products that bring unsurpassed value in efficacy and safety. Avior has an excellent management team, a strong advisory board, supportive partners, dedicated scientists, and knowledgeable clinicians that position us to be successful.
Contact Phone:
+19192006033
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 7/2021 | Grant | 1 | $256k |
National Science Foundation National Science Foundation |
2/2021 | Debt Financing | $0 |
North Carolina Biotechnology Center North Carolina Biotechnology Center |
12/2018 | Debt Financing | 1 | $250k |
North Carolina Biotechnology Center North Carolina Biotechnology Center |
2/2021 | Debt Financing | 1 | $25k |
North Carolina Biotechnology Center North Carolina Biotechnology Center |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|